View Press Releases

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

March 19, 2024

CD Formulation, a company in the field of biopharmaceutical studies, is revolutionizing the way impurity determination is conducted in the industry. With the use of advanced technology and cutting-edge methodologies, CD Formulation offers accurate and reliable testing for a wide range of impurities, ensuring the safety and effectiveness of pharmaceutical products. The expertise in organic impurity testing allows for thorough analysis of complex compounds present in biopharmaceuticals, providing valuable insights for researchers and manufacturers. The company's commitment to quality and innovation is evident in its comprehensive services, which include inorganic impurity testing, heavy metal analysis, elemental impurity testing, residual solvent testing, and more.

With the growing demand for safe and effective pharmaceutical products, the need for reliable impurity testing has become increasingly important. CD Formulation's expertise in genotoxic impurity testing allows for the identification and quantification of potentially harmful substances in biopharmaceuticals. By utilizing state-of-the-art equipment and rigorous testing protocols, CD Formulation ensures that only the highest quality products reach the market, providing peace of mind for both researchers and consumers alike.

In addition to genotoxic impurity testing, CD Formulation also offers analysis of nitrosamine impurities, a class of compounds that have gained significant attention in recent years due to their potential carcinogenic properties. By leveraging expertise in this area, CD Formulation accurately detects and quantifies nitrosamine impurities in pharmaceutical products, ensuring compliance with regulatory standards and maintaining the safety of patients.

Furthermore, CD Formulation's commitment to excellence extends to its heavy metal testing services in pharmaceuticals. With years of experience, CD Formulation accurately determines the levels of heavy metals present in pharmaceutical products, ensuring compliance with regulatory limits and safeguarding public health.

In short, CD Formulation’s comprehensive approach to impurity testing sets it apart as a trusted partner for biopharmaceutical companies seeking reliable and accurate analytical services. Meanwhile, its dedication to quality, accuracy, and innovation in impurity determination also makes it a valuable resource for the biopharmaceutical industry.

“As the industry continues to advance, CD Formulation remains at the forefront of impurity testing, said the Marketing Chief of CD Formulation. “With a wide range of services including organic impurity testing, genotoxic impurities testing, analysis of nitrosamine impurities, and heavy metal testing, were well-prepared to meet the evolving needs of researchers and manufacturers in ensuring the safety and efficacy of pharmaceutical products.

For more information, please visit to learn more.

About CD Formulation

With a strong focus on research and development, CD Formulation is committed to providing cutting-edge solutions for drug delivery systems and formulations. Over the past few years, CD Formulation has shown strong expertise in tailoring its services to meet the specific needs of clients and deliver high-quality products that meet the highest regulatory standards.